Takeda Pharmaceutical are launching an open innovation initiative inviting researchers to submit their proposals addressing novel therapeutic concepts/targets related to neurodegenerative disorders or genetic neurological diseases. One‑year projects will be funded up to JPY 10,000,000 or equivalent amount, including indirect costs.
Diseases of particular interest: amyotrophic lateral sclerosis, frontotemporal lobar degeneration, Alzheimer’s disease, Parkinson’s disease, multiple system atrophy, Down’s syndrome with Alzheimer’s disease, cerebral amyloid angiopathy...